Latest News & Features
Americas
Biopharmaceutical company Amgen and drug manufacturer Arrowhead Pharmaceuticals have entered into two agreements to develop and commercialise RNA interference therapies for cardiovascular disease. 3 October 2016
Americas
US drugs company Pfizer has filed a complaint against India-based generics company Aurobindo Pharma for allegedly infringing it patents centring on the drug Toviaz. 3 October 2016
Africa
More than 1,000 protesters representing different patient groups marched on September 27 in Pretoria, South Africa, to demand that the Department of Trade and Industry amends the patent law on medicine supply. 30 September 2016
Americas
Amgen has filed a complaint against Cipla for allegedly infringing a patent centring on Sensipar, which treats an overactive thyroid. 30 September 2016
Big Pharma
Fake drugs cost EU pharmaceutical companies up to €10.2 billion annually, a new report from the European Union Intellectual Property Office has revealed. 29 September 2016
Big Pharma
Biotechnology company Oncodesign is set to acquire pharmaceutical company GSK’s François Hyafil Research Centre in Essonne, France. 29 September 2016
Americas
Biotechnology company Genzyme has sued generic manufacturer Mylan in a lawsuit claiming that the company has infringed one of Genzyme’s patents covering the Clolar injection drug. 28 September 2016
Americas
Amgen has filed a complaint against Indian drug company Micro Labs for allegedly infringing a patent centring on Sensipar. 28 September 2016
Big Pharma
Clifford Chance has hired Stephen Reese as a partner in the firm’s London office. 28 September 2016
Americas
Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture. 28 September 2016